Authors
Loading...
Bioinformatics and immunohistochemistry assays show TMEM120B promotes stemness and drug resistance in breast cancer cells, highlighting a therapeutic target.
Hu et al. (2024) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: